prednisolone metasulphobenzoate
Selected indexed studies
- Prednisolone metasulphobenzoate foam retention enemas suppress the hypothalamo-pituitary-adrenal axis. (Aliment Pharmacol Ther, 1994) [PMID:8038357]
- Oral prednisolone metasulphobenzoate in the treatment of active ulcerative colitis. (Scand J Gastroenterol, 2003) [PMID:12795466]
- Rectally administered prednisolone--evidence for a predominantly local action. (Gut, 1980) [PMID:7399322]
_Worker-drafted node — pending editorial review._
Connections
prednisolone metasulphobenzoate is a side effect of
Sources
- Prednisolone metasulphobenzoate foam retention enemas suppress the hypothalamo-pituitary-adrenal axis. (1994) pubmed
- Oral prednisolone metasulphobenzoate in the treatment of active ulcerative colitis. (2003) pubmed
- Rectally administered prednisolone--evidence for a predominantly local action. (1980) pubmed
- Steroid acne with oral prednisolone metasulphobenzoate. (1994) pubmed
- Prednisolone levels in the plasma and urine: a study of two preparations in man. (1975) pubmed
- A comparison of sucralfate and prednisolone enemas in the treatment of active distal ulcerative colitis. (1989) pubmed
- Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis. (1985) pubmed
- A comparison of prednisolone enemas with low-dose oral prednisolone in the treatment of acute distal ulcerative colitis. (1984) pubmed
- The effect of rectally administered steroids on bone turnover: a comparative study. (1998) pubmed
- Rectal steroids suppress bone formation in patients with colitis. (1997) pubmed